SCHEMBL11255857

SCHEMBL11255857

OCc1cc(Oc2ccccc2)ccc1Cl

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 3/20 0.53
RHEB Q15382 3/20 0.47
KMO O15229 1/20 0.45
NR1H2 P55055 2/20 0.44
NR1H3 Q13133 1/20 0.44
BAX Q07812 1/20 0.44
PGR P06401 1/20 0.43
TSHR P16473 1/20 0.43
GSTP1 P09211 1/20 0.42
TTR P02766 1/20 0.41
HSP90AA1 P07900 1/20 0.41
AKR1C3 P42330 1/20 0.41
HDAC1 Q13547 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
MAOB P27338 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25960524 0.86 LTA4H (0.53) LTA4HRHEBKMONR1H2NR1H3
SCHEMBL11185908 0.84 LTA4H (0.44) LTA4HKMONR1H2BAXPGR
SCHEMBL3532436 0.82 DPP4 (0.49) LTA4HKMOPGRTSHRMAOB
SCHEMBL10836783 0.82 PGR (0.43) LTA4HKMONR1H2BAXPGR
SCHEMBL994959 0.82 HTR2A (0.52) LTA4HKMOPGRTSHR
SCHEMBL2093112 0.80 LTA4H (0.55) LTA4HNR1H2BAXTSHRGSTP1
SCHEMBL5784934 0.79 LTA4H (0.53) LTA4HRHEBNR1H2BAXTSHR
SCHEMBL20439168 0.79 LTA4H (0.53) LTA4HNR1H2BAXTSHRGSTP1
SCHEMBL11391950 0.79 LTA4H (0.53) LTA4HRHEBNR1H2BAXTSHR
SCHEMBL6184207 0.79 LTA4H (0.53) LTA4HNR1H2BAXTSHRGSTP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2668191-A2 BENZOFURO[3,2-C]PYRIDINES AND RELATED ANALOGS AS SEROTONIN SUB-TYPE 6 (5-HT6) MODULATORS FOR THE TREATMENT OF OBESITY, METABOLIC SYNDROME, COGNITION AND SCHIZOPHRENIA Albany Molecular Research, Inc. (US) 2013-12-04 EP disclosed
WO-2012099952-A2 BENZOFURO[3,2-C] PYRIDINES AND RELATED ANALOGS AS SEROTONIN SUB-TYPE 6 (5-HT6) MODULATORS FOR THE TREATMENT OF OBESITY, METABOLIC SYNDROME, COGNITION AND SCHIZOPHRENIA ALBANY MOLECULAR RESEARCH, INC. (US) 2012-07-26 WO disclosed
US-4366325-A Process for the preparation of 3-phenoxy-benzaldehydes BAYER AKTIENGESELLSCHAFT (DE) 1982-12-28 US disclosed
EP-0028714-B1 PROCESS FOR THE PREPARATION OF 3-PHENOXYBENZALDEHYDES BAYER AG (DE) 1982-09-15 EP disclosed
EP-0028714-A1 Process for the preparation of 3-phenoxybenzaldehydes BAYER AG (DE) 1981-05-20 EP disclosed